MedTrace Logo

Mitopure™ (Proprietary Urolithin A) Bioavailability in Healthy Adults

NCT04160312 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-04-10

No results posted yet for this study

Summary

This is a single-center, two-period, crossover, randomized, open labelled study enrolling 100 healthy subjects to evaluate the Urolithin A producer status and to compare bioavailabilty of direct dietary supplementation with Mitopure™ (proprietary Urolithin A) to dietary exposure with pomegranate juice

Conditions

  • Healthy
  • Healthy Aging

Interventions

DIETARY_SUPPLEMENT

Mitopure™ (Proprietary Urolithin A)

Fruit flavored sachet containing fixed dose of Mitopure™ (Proprietary Urolithin A)

DIETARY_SUPPLEMENT

Pomegranate Juice

100% Pomegranate juice (approximately 1 glass equivalent)

Sponsors & Collaborators

  • Atlantia Food Clinical Trials

    collaborator INDUSTRY

  • Amazentis SA

    lead INDUSTRY

Principal Investigators

  • Ali Keshavarzian, MD · Rush University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-08
Primary Completion
2020-02-29
Completion
2020-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04160312 on ClinicalTrials.gov